Genetic

NIH database links genetics, medical info

The NIH says the information will help researchers find the genetic underpinnings of adult diseases.

Illumina whittles genome cost to $1,000

The company's set of 10 sequencers brings down genome decoding to $1,000 each.

Merck, Genzyme, Alnylam play RNA musical chairs

The three drugmakers launched into a series of sell-offs and acquisitions over the weekend.

FDA slams 23andMe over genetic testing device

FDA slams 23andMe over genetic testing device

By

Regulators say the company has not received approval for the device's touted functions.

Quest joins breast cancer gene-testing market

The diagnostics firm is undercutting Myriad's cost by almost $1,000.

Genetic testing firm airs TV spot as part of $5M ad buy

Genetic testing firm airs TV spot as part of $5M ad buy

By

23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.

Myriad's loss a win for innovation, say the victors

Myriad's loss a win for innovation, say the victors

By

Merely isolating genes can't win you a patent, said the Supreme Court -- and that stands to fuel scientific inquiry in the age of personalized medicine

Pfizer effort urges lung cancer patients to get gene tests

Pfizer effort urges lung cancer patients to get gene tests

By

Pfizer Oncology has recruited Desperate Housewives and West Wing star Kathryn Joosten to feature in a national education campaign titled Lung Cancer Profiles, which aims to reduce stigma and plug molecular testing of the disease as the company deepens its investment in genetically-targeted oncology therapies.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters